Franklin Street Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Hold
1,431
0.02% 148
2026
Q1
$280K Sell
1,431
-407
-22% -$79.1K 0.02% 142
2025
Q4
$319K Hold
1,838
0.02% 134
2025
Q3
$350K Hold
1,838
0.02% 126
2025
Q2
$330K Hold
1,838
0.02% 134
2025
Q1
$311K Hold
1,838
0.02% 134
2024
Q4
$277K Hold
1,838
0.02% 144
2024
Q3
$285K Hold
1,838
0.02% 143
2024
Q2
$252K Hold
1,838
0.02% 146
2024
Q1
$245K Buy
+1,838
New +$238K 0.02% 150
2022
Q1
Sell
-1,631
Closed -$282K 160
2021
Q4
$282K Sell
1,631
-476
-23% -$72.4K 0.02% 134
2021
Q3
$306K Hold
2,107
0.03% 128
2021
Q2
$278K Hold
2,107
0.02% 129
2021
Q1
$270K Sell
2,107
-6
-0.3% -$739 0.03% 131
2020
Q4
$252K Sell
2,113
-30
-1% -$3.66K 0.02% 128
2020
Q3
$245K Buy
2,143
+36
+2% +$4.25K 0.03% 126
2020
Q2
$240K Buy
+2,107
New +$223K 0.03% 125
2020
Q1
Sell
-1,980
Closed -$211K 138
2019
Q4
$211K Hold
1,980
0.03% 144
2019
Q3
$212K Buy
+1,980
New +$203K 0.03% 143
2019
Q1
Sell
-2,428
Closed -$202K 160
2018
Q4
$202K Buy
+2,428
New +$228K 0.03% 133

Other funds holding DGX

Franklin Street Advisors's DGX Position: Q2 2026 in Review

Franklin Street Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,431 shares worth $303K. The position accounts for 0.02% of the portfolio, ranked #148.

Franklin Street Advisors first reported a position in DGX in Q4 2018 and has held it in 20 quarters since. The position peaked at $350K in Q3 2025. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Franklin Street Advisors held 1,431 shares of Quest Diagnostics worth $303K as of Q2 2026.
  • Franklin Street Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.02% of Franklin Street Advisors's portfolio in Q2 2026, its #148 holding.
  • Franklin Street Advisors first reported a position in Quest Diagnostics in Q4 2018 and has held it in 20 quarters since.
  • Franklin Street Advisors's Quest Diagnostics position peaked at $350K in Q3 2025.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.